Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Rh-catalyzed method for benzimidazo[1,2-a]quinolines using ionic liquids. High yield, additive-free process for pharma intermediates.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Patent CN115385916B reveals high-yield chiral synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Novel AlCl3-catalyzed route offers high Z-selectivity and mild conditions for scalable phthalide intermediate manufacturing.
Patent CN112142680B details a metal-free visible light method for 3-trifluoroalkylquinoxalinones, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN105111228A reveals a novel 5,5'-tetralone chiral phosphoric acid with superior acidity and enantioselectivity for cost-effective pharmaceutical intermediate manufacturing.
Novel Ru-catalyzed transfer hydrogenation method for 3-acylpyrroles. High atom economy, scalable process for reliable pharmaceutical intermediate supply and cost reduction.
Discover advanced ferrocene-based PNN ligands from patent CN114644663A for high-efficiency ketone hydrogenation, offering reliable supply and cost-effective pharma intermediate manufacturing.
Patent CN108586527B reveals a metal-free visible light method for aryl phosphonates. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable green synthesis.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral styrenes. Discover cost-effective, high-ee synthetic routes for pharmaceutical intermediates.
Novel metal-free oxidative cyclization route for triazole intermediates. High yield, scalable process for pharmaceutical applications reducing heavy metal waste.
Novel visible-light mediated synthesis of 2-acyl-9H-pyrrolo[1,2-a]indoles from N-propargyl indoles. Offers mild conditions, high yield, and scalable routes for pharmaceutical intermediates.
Patent CN101143862B details novel chiral ionic thiourea catalysts offering high enantioselectivity and recyclability for pharmaceutical intermediate manufacturing.
Patent CN112209947A discloses a mild, high-yield organocatalytic route to chiral indoxazinones with potent anticancer activity, offering significant cost reduction in API manufacturing.
Patent CN110156658A reveals efficient chiral phosphoric acid catalysis for triarylmethane derivatives ensuring high purity and scalable supply chain solutions.
Patent CN113307778A reveals a mild Mo/Cu-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Rh-catalyzed C-H activation for trifluoromethyl enaminones. High purity pharmaceutical intermediates with scalable cost reduction.
Patent CN106478719B details a novel camphor-based chiral catalyst. Offers high selectivity and metal-free advantages for pharmaceutical intermediates manufacturing cost reduction.
Patent CN113307790B reveals a metal-free oxidative cyclization route for high-purity triazole intermediates, offering significant cost reduction and scalable manufacturing capabilities.
Patent CN102491862A introduces a green aqueous Suzuki coupling method for biaryl compounds, offering significant cost reduction and simplified supply chain for pharmaceutical intermediates.